1.PCOS consensus. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41–47.
2.PCOS consensus. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril 2004; 81: 19–25.
3.Balen, AH, Dresner, M, Scott, EM, et al. Should obese women with polycystic ovary syndrome receive treatment for infertility? BMJ 2006; 332: 434–435.
4.Nelson, SM, Fleming, RF. The preconceptual contraception paradigm: obesity and infertility. Hum Reprod 2007; 22: 912–915.
5.Reaven, GM. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr 2005; 25: 391–406.
6.Moran, LJ, Noakes, M, Clifton, PM, et al. Dietary composition in restoring reproductive and metabolic physiology in overweight women with PCOS. J Clin Endocrinol Metab 2003; 88: 812–819.
7.Stamets, K, Taylor, DS, Kunselman, A, et al. A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with PCOS. Fertol Steril 2004; 81: 630–637.
8.Crosignani, PG, Colombo, M, Vegetti, W, et al. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 2003; 18: 1928–1932.
9.Wiksten-Almstromer, M, Hirschberg, AL, Hagenfeldt, K. Prospective follow-up of menstrual disorders in adolescence and prognostic factors. ACTA Obstet Gynecol Scan 2008; 87: 1162–1168.
10.Beckers, NG, Platteau, P, Eijkemans, R, et al. The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women. Eu J Endocrinol 2006; 155: 355–363.
11.Pildes, RB. Induction of ovulation with clomiphene. Am J Obstet Gynecol 1965; 15: 466–479.
12.Dehbashi, S, Vafaei, H, Persanezhad, M, et al. Time of initiation of clomiphene citrate and pregnancy rate in polycystic ovary syndrome. Int J Gynaecol Obstet 2006; 93: 44–48.
13.Moll, E, Bossuyt, PM, Korevaar, JC, et al. Effect of clomiphene citrate plus metformin and clomiphene citrate plus placebo on induction of ovulation in women with newly diagnosed PCOS: randomised double-blind clinical trial. BMJ 2006; 332: 1485.
14.Legro, RS, Barnhart, HX, Schlaff, WD, et al. Clomiphene, metformin, or both for Infertility in the PCOS. N Engl J Med 2007; 356: 551–566.
15.Koustra, E, White, DM, Franks, S. Modern use of CC in induction of ovulation. Hum Reprod Update 1997; 3: 359–365.
16.Imani, B, Eijkemans, MJ, te Velde, ER, et al. Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 1998; 83: 2361–2365.
17.Rossing, MA, Daling, JR, Weiss, NS, et al. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; 33: 771–776.
18.Homburg, R. Clomiphene citrate-end of an era? A mini review. Hum Reprod 2005; 20: 2043–2051.
19.Roumen, FJ, Doesburg, WH, Rolland, R. Treatment of infertile women with a deficient postcoital test with two antiestrogens: clomiphene and tamoxifen. Fertility and Sterility 1984; 41: 237–243.
20.Van Santbrink, EJ, Fauser, BC. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low-dose step-up and step-down dose regimens. J Clin Endocrinol Metab 1997; 82: 3597–3602.
21.LaMarca, A, Morgante, G, Palumbo, M, et al. Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with PCOS. Fertil Steril 2002; 78: 1234–1239.
22.Coffler, MS, Patel, K., Dahan, MH, et al. Enhanced granulosa cell responsiveness to FSH during insulin infusion in women with PCOS treated with pioglitazone. J Clin Endocrinol Metab 2003; 88: 5624–5631.
23.Lord, JM, Flight, IH, Norman, RJ. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 2003; 327: 951–953.
24.Legro, RS, Zaino, RJ, Demers, LM, et al. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in PCOS. Am J Obstet Gynecol 2007; 196: 402–410.
25.Glueck, CJ, Goldenberg, N, Pranikoff, J, et al. Height, weight and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 2004; 19: 1323–1330.
26.Garcia-Velasco, JA, Moreno, L, Pacheco, A, et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 2005; 84: 82–87.
27.Bayar, U, Basaran, M, Kiran, S, et al. Use of an aromatase inhibitor in patients with polycystic ovary syndrome: a prospective randomized trial. Fertil Steril 2006; 86: 1447–1451.
28.Tulandi, T, Martin, J, Al-Fadhli, R, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 2006; 85: 1761–1765.
29.Bayram, N, van Wely, M, van Der Veen, F. Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev 2001; 2:CD002121.
30.Mulders, AG, Eijkemans, MJ, Imani, B, et al. Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility. Reprod BioMed Onl 2003; 7: 48–56.
31.Zawadski, JK, Dunaif, A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif, A, Givens, JR, Haseltine, F, eds. Polycystic Ovary Syndrome. Boston: Blackwell Scientific, 1992: 377–384.
32.Azziz, R, Carmina, E, Dewailly, D, et al. Position statement: criteria for defining PCOS as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 2006; 91: 4237–4245.
33.Rizk, B, Aboulghar, M. Modern management of ovarian hyperstimulation syndrome. Hum Reprod 1991; 6: 1082–1087.
34.Rizk, B, Smitz, J. Ovarian hyperstimulation syndrome after superovulation for IVF and related procedures. Hum Reprod 1992; 7: 320–327.
35.Rabau, E, Serr, DM, David, A, et al. Human menopausal gonadotrophin for anovulation and sterility. Am J Gynecol 1967; 98: 92–98.
36.Rizk, B, Aboulghar, MA. Classification, pathophysiology and management of ovarian hyperstimulation syndrome. In: Brinsden, P, ed. A Textbook of In-vitro Fertilization and Assisted Reproduction, Second Edition. Carnforth-Lancs, UK: The Parthenon Publishing Group, 1999: 131–155.
37.Rizk, B. Ovarian hyperstimulation syndrome: epidemiology, pathophysiology. In: Prevention and Management. Cambridge: Cambridge University Press, 2006.
38.Rizk, B, Aboulghar, MA, Smitz, J, RonEl, R. The role of vascular endothelia growth factor and interleukins in the pathogenesis pf severe ovarian hyperstimulation syndrome. Hum Reprod Update 1997; 3: 255–266.
39.Rizk, B. Complications of ovulation induction II Ovarian hyperstimulation syndrome. In Dickey, RP, Brinsden, PR, Pyrzak, R, eds. Manual of Intrauteine Insemination and Ovulation Induction. Cambridge: Cambridge University Press, 2010: 152–160.
40.Rizk, B, Aboulghar, M. Ovarian hyperstimulation syndrome. In: Rizk, B, Aboulghar, M, eds. Ovarian Stimulation. Cambridge: Cambridge University Press, 2011: 111–137.
41.Mathur, RS, Akande, AV, Keay, SD, et al. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 2000; 73: 901–907.
42.Lyons, CA, Wheeler, CA, Frishman, GN, et al. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod 1994; 9: 792–799.
43.Rizk, B, Doyle, P, Tan, SL, et al. Perinatal outcome and congenital malformations in in-vitro fertilizatioin babies from the Bourn-Hallam group. Human Reprod 1991; 6(9): 1259–1264.
44.Tan, SL, Doyle, P, Campbell, S, et al. Obstetric outcome of in-vitro fertilization pregnancies compared to naturally conceived pregnancies. Am J Obstet and Gynecol 1992; 167(3): 778–784.
45.Hole, J, Porter, KB, Taylor, SK, et al. Multiple pregnancy following IVF. In: Rizk, B, ed. Ultrasonography in Reproductive Medicine and Infertility. Cambridge: Cambridge University Press, 2010: 291–296.
46.Jauniaux, ERM, Rizk, B. Pregnancy After Assisted Reproductive Technology. Cambridge: Cambridge University Press, 2011: 1–3.